Neglected Tropical Disease Drug Discovery Booster
This multi-company collaborative project with the Drugs for Neglected Diseases Initiative (DNDi) is focused on...
Back to List
Merck
COLLABORATIONS
SHOWING 5 of 20 COLLABORATIONS
See All
Pat-INFORMED – The Gateway to Medicine Patent Information
Pat-INFORMED, a private-public partnership between the World Intellectual Property Organisation, the...
TransCelerate Biopharma
TransCelerate is a nonprofit organization with the mission to collaborate across the biopharmaceutical...
AbbVie, Astellas Pharma Inc, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., GlaxoSmithKline, Johnson & Johnson, Merck, MSD, Pfizer Inc, Sanofi, UCB
Access Accelerated Initiative
Tackling the growing burden of non-communicable diseases in low and middle-income countries and supporting...
Access Accelerated, Almirall, Astellas Pharma Inc, Bayer AG, Bristol-Myers Squibb, Celgene, Chiesi Farmaceutici, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., International Federation of Pharmaceutical Manufacturers & Associations, Johnson & Johnson, Menarini Group, Merck, MSD, Novartis, Pfizer Inc, Sanofi, Servier, Shionogi & Co., Ltd., Sumitomo Dainippon, Takeda Pharmaceutical Company Limited, UCB
The London Declaration on NTDs
On 30 January 2012, pharmaceutical companies, donors, endemic countries and non-government organisations came...
AbbVie, Bayer AG, Bristol-Myers Squibb, Eisai, GlaxoSmithKline, Johnson & Johnson, Merck, MSD, Novartis, Pfizer Inc, Sanofi
SHOWING 5 of 20 COLLABORATIONS
See All